326 related articles for article (PubMed ID: 20667042)
1. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
[TBL] [Abstract][Full Text] [Related]
2. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
Saw CL; Hannach B; Petrazsko T; Nickerson P
Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
[TBL] [Abstract][Full Text] [Related]
3. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
Reil A; Keller-Stanislawski B; Günay S; Bux J
Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
Curtis BR; McFarland JG
Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
[TBL] [Abstract][Full Text] [Related]
5. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
Keller-Stanislawski B; Reil A; Günay S; Funk MB
Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
[TBL] [Abstract][Full Text] [Related]
6. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
[TBL] [Abstract][Full Text] [Related]
7. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
8. Antibody-mediated (immune) transfusion-related acute lung injury.
Bux J
Vox Sang; 2011 Jan; 100(1):122-8. PubMed ID: 21175662
[TBL] [Abstract][Full Text] [Related]
9. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
10. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-related acute lung injury (TRALI) in graft by blood donor antibodies against host leukocytes.
Goodwin J; Tinckam K; denHollander N; Haroon A; Keshavjee S; Cserti-Gazdewich CM
J Heart Lung Transplant; 2010 Sep; 29(9):1067-70. PubMed ID: 20627626
[TBL] [Abstract][Full Text] [Related]
12. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.
Flesch BK; Petershofen EK; Bux J
Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007
[TBL] [Abstract][Full Text] [Related]
13. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury.
Toy P; Hollis-Perry KM; Jun J; Nakagawa M
Transfusion; 2004 Dec; 44(12):1683-8. PubMed ID: 15584980
[TBL] [Abstract][Full Text] [Related]
14. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
15. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report.
Muro M; Rivera J; Botella C; Campillo JA; Ferrer F; Alvarez-López MR
Transfus Apher Sci; 2008 Jun; 38(3):209-12. PubMed ID: 18462996
[TBL] [Abstract][Full Text] [Related]
17. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
Nicolle AL; Chapman CE; Carter V; Wallis JP
Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
[TBL] [Abstract][Full Text] [Related]
19. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury.
Nishimura M; Hashimoto S; Takanashi M; Okazaki H; Satake M; Nakajima K
Transfus Med; 2007 Apr; 17(2):129-34. PubMed ID: 17430469
[TBL] [Abstract][Full Text] [Related]
20. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital.
Nakagawa M; Toy P
Transfusion; 2004 Dec; 44(12):1689-94. PubMed ID: 15584981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]